Coventry, the leader and creator of the secondary market for life insurance, announced today that it has paid more than $6 billion to policyowners for their unwanted or underperforming life insurance policies. “Six billion isn’t just a number, it’s a reflection of the lives we’ve helped change,” said Reid Buerger, CEO of Coventry. “Behind every policy is a story. We’re proud to have helped so many policyowners turn their unwanted…

Coventry, the leader and creator of the secondary market for life insurance, once again secured the top spot in the life settlement industry—ranking first for both total number of policies purchased and total face value—according to industry league tables published by The Deal, a financial intelligence and data company. Coventry and its affiliate, Life Equity, purchased more than 1,300 policies in 2024, representing over $1.4 billion in face value––more than…

Coventry today announced that it has exceeded more than $100 million in Enhanced Cash ValueSM (ECVSM) since the program launched, signaling extraordinary demand from advisors and policyowners seeking a faster and more beneficial alternative to the cash surrender value offered by life insurance carriers. “The momentum we’ve seen so far is remarkable,” said Reid Buerger, CEO of Coventry. “Enhanced Cash Value is delivering exactly what the market needed: speed, simplicity,…

The program will provide enhanced cash values using only a policy illustration. FORT WASHINGTON, PA, April 22, 2025: Coventry, a leading creator of longevity and life insurance products for the life insurance industry, today announced the launch of an Enhanced Cash Value program that enables seniors to access significantly more cash than they would otherwise receive from the cash surrender value in their Universal Life insurance policies, without the need…

The Study Measures Lapetus’s Actual-to-Expected Results A comprehensive new study conducted by Professors Daniel Bauer and Nan Zhu has revealed serious flaws in the life expectancy estimates produced by Lapetus Solutions, Inc., highlighting that the company significantly understates the actual life expectancies of insureds. The findings raise serious concerns about the accuracy of Lapetus’s mortality predictions, which could have serious repercussions for life settlement investors. The study utilized an Actual-to-Expected…

Coventry, the leader and creator of the secondary market for life insurance, today announced the appointment of Dan LaBert to Senior Vice President, Strategic Accounts. In his new role, LaBert will be responsible for developing and expanding strategic relationships with life insurance carriers and industry groups. “We’re thrilled to have Dan join us at Coventry. His vast experience and relationships will play a vital role in our continued efforts to…

FORT WASHINGTON, PA, SEPTEMBER 16, 2024: Coventry, the largest purchaser of life insurance policies in the secondary market, today announced it has committed an additional $300 million to fuel the expansion of its non-medically underwritten life settlement investments. “This expansion is a top priority for us and continues our trend of using proprietary capital, allowing us to make quick, independent buying decisions without relying on third parties or external approvals,”…

FORT WASHINGTON, PA, JULY 22, 2024: Coventry today released an independent, academic peer review confirming the results of an internal analysis of life expectancy estimates issued by leading life expectancy providers. That analysis found that estimates issued by Lapetus Solutions, Inc. are consistently the shortest by a wide margin—meaning that valuations based on Lapetus life expectancies could lead to significantly inflated asset values and investor losses. The review of the…

FORT WASHINGTON, PA, JUNE 10, 2024: Coventry, the leader and creator of the secondary market for life insurance, continues to rank first in the life settlement industry for both total number of policies purchased and total face value, according to industry league tables. The league tables, published by financial publication The Deal, are a comprehensive review of secondary market life settlement transactions. Coventry companies have held the top spot each…

FORT WASHINGTON, PA, May 7, 2024: Coventry today released the results of an internal review that found life expectancy estimates issued by Lapetus Solutions, Inc. are consistently and materially shorter than those issued by other life expectancy providers, potentially leading to the overvaluation of life insurance policies and investor losses. The results cast doubt on the accuracy of asset valuations based primarily on Lapetus life expectancies. After reviewing thousands of…